Abstract
AbstractEpigenetic memory is essential for life that governs the predefined functional features of cells. Recent evidence has indicated that the epigenetic modification provides a potential link to gene expression changes that may be involved in the development of various chronic diseases, and targeting the epigenome becomes a plausible method for treating diseases. Traditional herbal medicine has gradually entered the vision of researchers due to its low toxicity and its effectiveness in treating diseases. As a matter of fact, researchers found that the possessed epigenetic modification capacity of herbal medicine had the ability to combat the progression of the disease, such as various types of cancer, diabetes, inflammation, amnesia, liver fibrosis, asthma, and hypertension-induced renal injury. Studies on the epigenetic effects of herbal medicine will provide valuable insights into the molecular mechanisms of human diseases, which may lead to new therapeutic approaches and diagnoses. Thus, this review summarized the impact of herbal medicine and its bioactive components on disease epigenome as examples of how utilization of epigenetic plasticity could be useful as the basis for the future development of targeted therapies in chronic diseases.
Funder
National Natural Science Foundation of China
Guangdong Natural Science Foundation of China
“Thousand, Hundred, and Ten” Project of the Department of Education of Guangdong Province of China
Basic and Applied Research Major Projects of Guangdong Province of China
“Yang Fan” Project of Guangdong Province of China
Shantou Medical Health Science and Technology Plan
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Developmental Biology,Genetics,Molecular Biology
Reference135 articles.
1. Choi BC, McQueen DV, Puska P, Douglas KA, Ackland M, Campostrini S, et al. Enhancing global capacity in the surveillance, prevention, and control of chronic diseases: seven themes to consider and build upon. J Epidemiol Commun Health. 2008;62:391–7.
2. Bлacик Л, Cтyпницькa Г, Cyxoлoтюк A. Peculiarities of primary health care organization for patients suffering from chronic obstructive pulmonary disease jointly with coronary heart disease. Wiad Lek. 2017;70:466–9.
3. Ndagi U, Mhlongo N, Soliman ME. Metal complexes in cancer therapy-an update from drug design perspective. Drug Des Devel Ther. 2017;11:599–616.
4. Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20:953–66.
5. Traboulsi H, Guerrina N, Iu M, Maysinger D, Ariya P, Baglole CJ. Inhaled pollutants: the molecular scene behind respiratory and systemic diseases associated with ultrafine particulate matter. Int J Mol Sci. 2017;18:243.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献